Evidence map›Paper›PMID 30061183›Full record

ArticleBioscience reports2018

LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-β pathway.

Jiezhi Ma, Min Xue

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.International journal of molecular sciences · 2019
    Review
  16. LINK-A lncRNA Promotes Proliferation and Inhibits Apoptosis of Mantle Cell Lymphoma Cell by Upregulating Survivin.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  17. Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.Cancer drug resistance (Alhambra, Calif.) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jiezhi MaDepartment of Obstetrics and Gynecology, Xiangya Third Hospital, Central South University, Changsha City, Hunan Province, 410013, P.R. China.
Min XueDepartment of Obstetrics and Gynecology, Xiangya Third Hospital, Central South University, Changsha City, Hunan Province, 410013, P.R. China majiezhi@csu.edu.cn.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedCase-Control StudiesCell Line, TumorCell MovementFemaleGene Expression Regulation, NeoplasticHumansMiddle AgedOvarian NeoplasmsRNA, Long NoncodingTransforming Growth Factor beta1Up-RegulationLINK-A long non-coding RNA, humanRNA, Long NoncodingTGFB1 protein, humanTransforming Growth Factor beta1invasionLINK-A lncRNAmigrationovarian carcinomaTGF-β1

Identifiers

PMID30061183
PMCPMC6137249
OpenAlexW2887105403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.